Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Corneal collagen cross-linking in paediatric patients: two year follow-up results

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Cross-linking I

Session Date/Time: Monday 15/09/2014 | 14:30-16:30

Paper Time: 14:42

Venue: Capital Hall A

First Author: : M.Shah INDIA

Co Author(s): :    H. Nagaraj   R. Shetty   R. Hegde   C. Jayadev   K. Shetty  

Abstract Details

Purpose:

To evaluate the effectiveness and safety of corneal collagen crosslinking (CXL) in children (below 14 years of age group) with progressive keratoconus.

Setting:

Tertiary eye care centre ,Research and Post Graduate Institute ,Bangalore ,India

Methods:

Thirty eyes of 17 paediatric patients with established progressive keratoconus were included in the study. Pre-operative and post-operative UCVA, BCVA and pentacam were done in all cases. CXL was performed as per the standard protocol advised by Seiler et al., and patients were followed up at 6, 9, 12 and 24 months.

Results:

Mean age of the patients was 10.47 years with ten males and seven females. There was improvement in the mean postoperative UCVA, BCVA and spherical equivalent. The mean K1/K2 improved from 48.42/53.77 pre-operatively to 46.49/51.70 post-operatively at the end of 2 years. Three eyes of two patients with vernal keratoconjunctivitis (VKC) showed progression. There were no intra or post-operative complications.

Conclusions:

Corneal collagen crosslinking in paediatric patients is an effective and safe procedure to halt the progression of keratoconus. Management of VKC also forms an integral part of arresting progression of keratoconus in children in those afflicted.

Financial Interest:

NONE

Back to previous